DXS0:F:F-Xtrackers - SLI UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 215.85

Change

-3.30 (-1.51)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.13 (-0.47%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.39 (+0.78%)

USD 112.00B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 98.90B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.26 (-0.47%)

USD 92.14B
SXRZ:F iShares VII PLC - iShares Nikk..

+3.25 (+1.39%)

USD 57.35B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.09 (-0.57%)

USD 53.27B
VUSA:F Vanguard Funds Public Limited ..

-0.65 (-0.64%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.94 (-0.92%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.02 (-0.21%)

USD 40.47B
0ZC:F Zscaler Inc

-2.88 (-1.64%)

USD 37.92B

ETFs Containing DXS0:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.89% 57% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.89% 57% F 62% D
Trailing 12 Months  
Capital Gain 22.95% 64% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.95% 64% D 64% D
Trailing 5 Years  
Capital Gain 46.68% 71% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 46.68% 71% C- 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.16% 70% C- 67% D+
Dividend Return 9.16% 68% D+ 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.57% 53% F 83% B
Risk Adjusted Return 72.89% 81% B- 84% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike